Finance

Lists
42C:SGX
IX Biopharma Ltd
SGD 0.46
0.00%
(0.00) 1D
Nov 17, 10:40:58 AM GMT+8  ·   SGD
All symbols
SymbolPriceChange% Change
Generating top insights for 42C...
Open
SGD 0.46
High
SGD 0.47
Low
SGD 0.46
Mkt. cap
504.33M
Avg. vol.
9.32M
Volume
508.60K
52-wk high
SGD 0.62
52-wk low
SGD 0.11
EPS
-SGD 0.01
Shares outstanding
1.10B
No. of employees
37
Open
SGD 0.46
High
SGD 0.47
Low
SGD 0.46
Mkt. cap
504.33M
Avg. vol.
9.32M
Volume
508.60K
52-wk high
SGD 0.62
52-wk low
SGD 0.11
EPS
-SGD 0.01
Shares outstanding
1.10B
No. of employees
37
News stories
From web sources and news partners
About IX Biopharma Ltd
CEOEddy Lee
Employees37
Founded2004
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in SGD
Loading Previous Earnings...
Revenue
Net income
All values in SGD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.59M
1.59M
2.09M
2.71M
Cost of goods sold
1.18M
983.00K
1.08M
959.00K
Cost of revenue
1.18M
983.00K
1.08M
959.00K
Research and development expenses
203.00K
769.00K
1.31M
1.65M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.72M
1.71M
4.30M
3.36M
Operating expense
1.94M
2.48M
5.63M
5.00M
Total operating expenses
3.12M
3.46M
6.71M
5.96M
Operating income
-1.53M
-1.87M
-4.62M
-3.26M
Other non operating income
66.00K
79.00K
-243.00K
52.00K
EBT including unusual items
-1.03M
-915.00K
-5.01M
-3.33M
EBT excluding unusual items
-1.03M
-915.00K
-4.75M
-3.33M
Income tax expense
500.00
1.00K
7.00K
-
Effective tax rate
-0.05%
-0.11%
-0.14%
-
Other operating expenses
-
-
-
-
Net income
-1.03M
-916.00K
-5.02M
-3.33M
Net profit margin
-64.76%
-57.65%
-240.35%
-123.12%
Earnings per share
-
-
-
-
Interest and investment income
-
-
6.00K
-
Interest expense
-201.50K
-164.00K
-123.00K
-131.00K
Net interest expenses
-201.50K
-164.00K
-117.00K
-131.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.44M
-1.78M
-4.53M
-3.10M
Gain or loss from assets sale
-
-
-64.00K
-
Upcoming events
AI content may include mistakes. Learn more
Google apps